BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9193847)

  • 1. Effects of cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients.
    Hohage H; Arlt M; Brückner D; Dietl KH; Zidek W; Spieker C
    Clin Transplant; 1997 Jun; 11(3):225-30. PubMed ID: 9193847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
    Badiou S; Garrigue V; Dupuy AM; Chong G; Cristol JP; Mourad G
    Transplant Proc; 2006 Sep; 38(7):2314-6. PubMed ID: 16980076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid profiles in pediatric thoracic transplant recipients are determined by their immunosuppressive regimens.
    Law YM; Yim R; Agatisa P; Boyle GJ; Miller SA; Lawrence K; Webber SA
    J Heart Lung Transplant; 2006 Mar; 25(3):276-82. PubMed ID: 16507419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus.
    Trotter JF; Wachs ME; Trouillot TE; Bak T; Kugelmas M; Kam I; Everson G
    Liver Transpl; 2001 May; 7(5):401-8. PubMed ID: 11349259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral fructose load on serum uric acid and lipids in kidney transplant recipients treated with cyclosporine or tacrolimus.
    Zawiasa A; Szklarek-Kubicka M; Fijałkowska-Morawska J; Nowak D; Rysz J; Mamełka B; Nowicki M
    Transplant Proc; 2009; 41(1):188-91. PubMed ID: 19249511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum lipids and apolipoproteins in liver transplant recipients: a comparative study of cyclosporin A and FK 506.
    Krentz AJ; Cramb R; Dousset B; Mayer D; McMaster P; Buckels J; Smith JM; Nattrass M
    J Lab Clin Med; 1994 Sep; 124(3):381-5. PubMed ID: 7521895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-density lipoprotein oxidizability and the alteration of its fatty acid content in renal transplant recipients treated with cyclosporine/tacrolimus.
    Bakar F; Keven K; Dogru B; Aktan F; Erturk S; Tuzuner A; Erbay B; Nebioglu S
    Transplant Proc; 2009 Jun; 41(5):1630-3. PubMed ID: 19545695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal function and lipid metabolism in pregnant renal transplant recipients.
    Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
    Skalicka B; Kubanek M; Malek I; Vymetalova Y; Hoskova L; Podzimkova M; Kautzner J
    J Heart Lung Transplant; 2009 Jun; 28(6):598-604. PubMed ID: 19481021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine and tacrolimus: influence on cardiovascular risk factors.
    Hohage H; Hillebrandt U; Welling U; Zeh M; Heck M; Gerhardt UW; Suwelack BM
    Transplant Proc; 2005 Mar; 37(2):1036-8. PubMed ID: 15848615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New onset dyslipidemia after renal transplantation: is there a difference between tacrolimus and cyclosporine?
    Deleuze S; Garrigue V; Delmas S; Chong G; Swarcz I; Cristol JP; Mourad G
    Transplant Proc; 2006 Sep; 38(7):2311-3. PubMed ID: 16980075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study.
    Fernández-Miranda C; de la Calle A; Morales JM; Guijarro C; Aranda JL; Gómez-Sanz R; Gómez-Izquierdo T; Larumbe S; Moreno E; Rodicio JL; del Palacio A
    Clin Transplant; 1998 Apr; 12(2):136-41. PubMed ID: 9575402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy.
    Charco R; Cantarell C; Vargas V; Capdevila L; Lázaro JL; Hidalgo E; Murio E; Margarit C
    Liver Transpl Surg; 1999 May; 5(3):204-8. PubMed ID: 10226111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion from tacrolimus to cyclosporine could improve control of posttransplant diabetes mellitus after renal transplantation.
    Ramos-Cebrián M; Torregrosa JV; Gutiérrez-Dalmau A; Oppenheimer F; Campistol JM
    Transplant Proc; 2007 Sep; 39(7):2251-3. PubMed ID: 17889154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion from cyclosporine microemulsion to tacrolimus in stable kidney transplant patients with hypercholesterolemia is related to an improvement in cardiovascular risk profile: a prospective study.
    Marcén R; Chahin J; Alarcón A; Bravo J
    Transplant Proc; 2006 Oct; 38(8):2427-30. PubMed ID: 17097957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus.
    Chamienia A; Biedunkiewicz B; Król E; Debska-Slizień A; Rutkowski B
    Transplant Proc; 2006; 38(1):81-5. PubMed ID: 16504670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pravastatin on renal transplant recipients treated with cyclosporine--4-year follow-up.
    Yoshimura N; Ohmori Y; Tsuji T; Oka T
    Transplant Proc; 1994 Oct; 26(5):2632-3. PubMed ID: 7940820
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipid profile in renal transplant recipients under various immunosuppressive regimens.
    Montagnino G; Tarantino A; Aroldi A; Banfi G; Cesana B; Ponticelli C
    Transplant Proc; 1994 Oct; 26(5):2634-6. PubMed ID: 7940821
    [No Abstract]   [Full Text] [Related]  

  • 20. Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion.
    White M; Haddad H; Leblanc MH; Giannetti N; Pflugfelder P; Davies R; Isaac D; Burton J; Chan M; Azevedo E; Howlett J; Ignaszewski A; Busque S; Cantarovich M; Ferguson R; Genest J; Ross H
    J Heart Lung Transplant; 2005 Jul; 24(7):798-809. PubMed ID: 15982605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.